Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.

Slides:



Advertisements
Similar presentations
Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Advertisements

CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
HIV Testing in Health-Care Settings
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV TESTING AND DELIVERY PRELIMINARY POSITIVE HIV RESULT IN THE EMERGENCY DEPARTMENT TESTAZ PROGRAM AMY EDMONDS, MSW, LMSW PROGRAM COORDINATOR TESTAZ PROGRAM,
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Rapid HIV Tests Norman Moore, Ph.D. Director of Medical Affairs.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Enhanced Perinatal Surveillance, Georgia
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Helene Gayle Director, HIV, TB and Reproductive Health Bill and Melinda Gates Foundation HIV/AIDS in the African American Community: Confronting the Challenge.
HIV Testing in Health- Care Settings Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings U.S. Centers.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Florida Department of Health HIV/AIDS & Hepatitis Section Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
HIV/AIDS Prevention Committee Public Meeting November 21, 2013.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
Screening and Treatment for Gonorrhea and Chlamydia as an HIV Prevention Strategy: Rationale and Implementation Thomas Farley, MD MPH Tulane University.
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
HIV Screening: New Approaches and New Paradigms
STD Testing Protocols, STD Testing, and Discussion of Sexual Behaviors in HIV Clinics in Los Angeles County Melanie M. Taylor MD, MPH Los Angeles County.
Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.
HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis,
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics
African Americans and HIV: CA Office of AIDS Response Michelle Roland, MD Chief, Office of AIDS California Department of Public Health.
Universal HIV Testing Closing the Gap Peter A. Leone, MD Associate Professor of Medicine University of North Carolina Medical Director, NC HIV/STD Prevention.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
ABSTRACT Introduction: HIV infection is growing relatively fast among seniors. Among the clinical implications are that older patients have less ability.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis, STD,
Poverty and HIV Infection: NHBS National* and San Diego Findings Vanessa Miguelino-Keasling, MPH National HIV Behavioral Surveillance System.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
NC HIV/STD Screening Initiatives: HIV in the ER Brooke Hoots, MSPH Fall 2008 HIV/STD Update September 25, 2008.
John W. Hogan, M.D Howard University College of Medicine.
Routine Opt-Out HIV Testing UCLA / Pacific AIDS Education & Training Center (UCLA PAETC) CDC Routine HIV Testing Project 2011.
1 State of the State: HIV/STD in Texas Ann Robbins Texas Department of State Health Services June 2009.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
1 PHSKC 4/01 Epidemiology of HIV/AIDS Seattle-King County, WA HIV/AIDS Epidemiology Program Public Health - Seattle & King Co. (206) On the web.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014 Florida Department of Health HIV/AIDS Section Division of Disease.
Lower Hudson Valley Perinatal Network Serving Dutchess, Putnam, Rockland & Westchester Counties Presented at the Quarterly Education & Networking Conference.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Routine Opt-Out HIV Testing Texas STD Clinics James H. Lee, Senior Public Health Advisor HIV/STD Program Texas Department of State Health Services.
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
1 HIV/STD in Texas Ann Robbins Texas Department of State Health Services June 2009.
1 MSM Sexual Health Summit August 20, 2012 HIV/STD Prevention and Care Branch Texas Department of State Health Services.
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
CT and GC Screening: What about the guys?! Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Department of Health SUNY at Buffalo School of Medicine Buffalo,
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
Katarina Grande, HIV Surveillance Coordinator Casey Schumann, HIV Epidemiologist Wisconsin Department of Health Services Statewide Action Planning Group.
AIDS in Adolescents and Youngsters Prof. Jorge Peláez Mendoza M.D. Prof. Jorge Peláez Mendoza M.D. Obstetrics and Gynecology Department Obstetrics and.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Division of STD Prevention Centers for Disease Control and Prevention
Presentation transcript:

Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention Centers for Disease Control and Prevention Normalising HIV Testing: CDC’s Revised Recommendations for HIV Screening in Health Care Settings The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention

Presentation Outline Epidemiologic background Current testing Current recommendations and their effects The case for increased HIV testing Considerations for revising recommendations Summary

Number HIV infected 1,039,000 – 1,185,000 Number unaware of their HIV infection 252, ,000 (24%-27%) Estimated new infections 40,000 annually Awareness of HIV Status among Persons with HIV, United States Glynn M, Rhodes P HIV Prevention Conference

HIV Prevalence, NHANES White M White F Black M Black F Hispanic F Hispanic M White M White F Black M Black F Hispanic M Hispanic F Age yearsAge years - McQuillan et al, NCHS: JAIDS April 2006 Prevalence of HIV Antibody

Total Tested HIV Prevalence No. % Unrecognized HIV Infection No. % Age Group (yrs) (14)45(79) (17)37(70) (29)83(49) (37)41(30) ≥ (31)11(34) Race/Ethnicity White616127(21)23(18) Black444206(46)139(67) Hispanic466 80(17)38(48) Multiracial 86 16(19) 8(50) Other139 18(13) 9(50) Total1,767450(25)217(48) HIV Prevalence and Proportion of Unrecognized HIV Infection Among 1,767 MSM, by Age Group and Race/Ethnicity NHBS, Baltimore, LA, Miami, NYC, San Francisco MMWR June 24, 2005

Terminology Diagnostic testing: HIV testing based on clinical signs or symptoms Screening: HIV testing for all persons in a defined population Targeted testing: offering testing to subgroups at higher risk based on behavioral, clinical or demographic characteristics Opt-out testing: HIV testing after notifying the patient that the test will be done; consent is inferred unless the patient declines

Current Testing

Source of HIV Tests and Positive Tests HIV tests * HIV+ tests ** Private doctor/HMO44%17% Hospital, ED, Outpatient22%27% Community clinic (public)9%21% HIV counseling/testing5%9% Correctional facility0.6%5% STD clinic0.1%6% Drug treatment clinic0.7%2% *National Health Interview Survey, 2002 **Suppl. to HIV/AIDS surveillance, % - 44% of adults age have been tested million persons age tested annually in U.S.

Late HIV Testing is Common Supplement to HIV/AIDS Surveillance, Among 4,127 persons with AIDS*, 45% were first diagnosed HIV-positive within 12 months of AIDS diagnosis (“late testers”) Late testers, compared to those tested early (>5 yrs before AIDS diagnosis) were more likely to be: Younger (18-29 yrs) Heterosexual Less educated African American or Hispanic MMWR June 27, 2003 *16 states

Reasons for testing: late versus early testers Supplement to HIV/AIDS Surveillance,

Current Recommendations and their Effects

Recommendations for Testing Pregnant Women Routine, voluntary HIV testing as a part of prenatal care, as early as possible, for all pregnant women Simplified pretest counseling Flexible consent process

Number of cases Number of cases Estimated Number of Perinatally Acquired AIDS Cases, by Year of Diagnosis, – United States PACTG 076 & USPHS ZDV Recs ~95% reduction CDC HIV screening Recs Year of Diagnosis

Existing CDC Recommendations Adults and Adolescents Routinely recommend HIV counseling and testing in settings with HIV prevalence >1%

Recommendations Are Not Having Their Intended Effect in Acute Care Settings ED visits108 million107 million110 million Age million69.4 million69.6 million HIV serology215,000201,000163,000  Emergency Departments (EDs) account for 10% of all ambulatory care visits U.S. National Center for Health Statistics National Hospital Ambulatory Medical Care Survey

Rapid HIV Screening in Acute Care Settings Cook County ED, Chicago2.3% Grady ED, Atlanta2.7% Johns Hopkins ED, Baltimore3.2% King-Drew Med Center ED, Los Angeles1.3% Inpatients, Boston Medical Center3.8% New HIV+Study site

Existing CDC Recommendations Adults and Adolescents Routinely recommend HIV counseling and testing in settings with HIV prevalence >1% Targeted counseling and testing based on risk assessment

Characteristics, HIV-Positive Patients Identified in ED Screening N= 83 No previous test47 (57%) Risk factors MSM30 (34%) IDU 8 (10%) High risk hetero partner 3 (4%) No identified risk42 (51%) - Cook County Bureau of Health Services, 2003

Existing CDC Recommendations Adults and Adolescents Routinely recommend HIV counseling and testing in settings with HIV prevalence >1% Targeted counseling and testing based on risk assessment Routinely recommend HIV counseling and testing for patients seeking treatment for STDs

HIV Testing Practices in Emergency Departments Survey of 95 Academic EDs For patients with suspected STDs: – 93% screen for gonorrhea – 88% screen for chlamydia – 58% screen for syphilis – 3% screen for HIV - Wilson et al, 1999: Am J Emerg Med

The Case for HIV Screening

Criteria that Justify Routine Screening 1. Serious health disorder that can be detected before symptoms develop 2. Reliable, inexpensive, acceptable screening test 3. Treatment is more beneficial when begun before symptoms develop 4. Facilities for diagnosis and treatment should be available 5. Costs of screening are reasonable in relation to anticipated benefits -WHO Public Health Paper, 1968 Principles and Practice of Screening for Disease

Making HIV Screening a Routine Part of Medical Care Cook County Hospital ED, Chicago, Illinois Rapid testing since Oct 02 62% accept HIV testing 98% receive test results 3,802 patients screened 93 (2.4%) new HIV positive 80% entered HIV care (median 18 days)

Rapid HIV Screening in Medical Settings Demonstration ProjectNo. testedNo. (%) HIV+ New York City Bronx- Lebanon: 2 clinics, 1 ED 3,03961 (2%) Los Angeles 2 clinics, 1 ED 6,90975 (1.1%) Alameda County (Oakland) 1 ED 6,28384 (1.3%) Massachusetts 1 outpatient, 1 inpatient, 1 clinic 5,99445 (0.75%) Wisconsin 3 clinics 1,7636 (0.34%) CDC, preliminary data - Dec 2005

Lessons Learned Difficult to obtain separate written consent and provide counseling, yet still screen the large numbers of patients in health care settings. Sustainability will depend on streamlined systems, additional staff, or both.

Rationale for Revising Recommendations Many HIV-infected persons access health care but are not tested for HIV until symptomatic Effective treatment available Awareness of HIV infection leads to substantial reductions in high-risk sexual behavior Great deal of experience with HIV testing, including rapid tests

Mortality and HAART Use Over Time HIV Outpatient Study, CDC, Patients on HAART Deaths per 100 PY

Knowledge of HIV Infection and Behavior Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the U.S. Marks G, et al. JAIDS. 2005;39:446 After people become aware they are HIV- positive, the prevalence of high-risk sexual behavior is reduced substantially. Reduction in Unprotected Anal or Vaginal Intercourse with HIV-neg partners: HIV-pos Aware vs. HIV-pos Unaware 68%

Cost Effectiveness Cost-effectiveness of screening for HIV in the era of HAART. Sanders G, et al. NEJM “The cost-effectiveness of routine HIV screening in health care settings, even in relatively low- prevalence populations, is similar to that of commonly accepted interventions, and such programs should be expanded.”

Proposed Recommendations Adults and Adolescents - I Routine, voluntary HIV screening for all persons in health care settings, not based on risk or prevalence Opt-out HIV testing with the opportunity to ask questions and the option to decline Include HIV consent with general consent for care; separate signed informed consent is not required Prevention counseling in conjunction with HIV screening in health care settings is not required

Proposed Recommendations Adults and Adolescents - II Communicate test results in same manner as other diagnostic/screening tests Provide clinical HIV care or establish reliable referral to qualified providers Repeat HIV screening of persons with known risk at least annually

Proposed Revisions Adults and Adolescents - III Intended for all health care settings, including inpatient services, EDs, urgent care clinics, STD clinics, TB clinics, public health clinics, community clinics, substance abuse treatment centers, correctional health facilities, primary care settings Low prevalence settings: Initiate screening If HIV prevalence shown to be <0.1%, screening is no longer be warranted

Summary There is an urgent need to increase the proportion of persons who are aware of their HIV-infection status Expanded, routine, voluntary, opt-out screening in health care settings is needed Such screening is cost-effective Revised recommendations: September 2006